Le glutathion ne prsente pas de danger Actuellement, les tudes scientifiques nont dmontr aucun danger concernant la prise de glutathion
Dosing 1 capsule 1-2 times daily on an empty stomach or as directed
Phase I Safety Profile: While topical and low-dose injectable formulations demonstrate high tolerance and minimal systemic toxicity, there is no formal Phase I safety data for chronic 85 mg/day intranasal delivery in humans
Frohman, Pulsatile Secretion of Growth Hormone (GH) Persists during Continuous Stimulation by CJC-1295, a Long-Acting GH-Releasing Hormone Analog, The Journal of Clinical Endocrinology & Metabolism, Volume 91, Issue 12, 1 December 2006, Pages 47924797, (3) Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM
S.OliveiraC
Oligopeptide-3 is a peptide